NCT04507971View on ClinicalTrials.gov

Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Obesity, Metabolically Benign
Interventions
BIOLOGICAL

MET-3

Human microbiome supplementation derived from bacterial strains isolated from fecal matter and grown in a laboratory environment

Trial Locations (1)

M5C2N8

RECRUITING

Inquis Clinical Research, Toronto

Sponsors

Lead Sponsor

NuBiyota
All Listed Sponsors
lead

NuBiyota

OTHER

NCT04507971 - Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia | Biotech Hunter | Biotech Hunter